+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Immune biomarkers and long‑term graft survival: a prospective follow‑up of 457 kidney transplant recipients



Immune biomarkers and long‑term graft survival: a prospective follow‑up of 457 kidney transplant recipients



Polish Archives of Internal Medicine 127(3): 178-183



INTRODUCTION    Antibodies against donor human leukocyte antigens (HLAs) play a significant role in the pathogenesis of antibody‑mediated rejection, although their relevance during the late posttransplant period is unknown. A non‑HLA polymorphic antigenic system, like major histocompatibility class I chain‑related antigen A (MICA), might be another target for antibody responses involved in rejection. OBJECTIVES    We conducted a 7‑year prospective study to determine the effect of positivity for anti‑HLA and anti‑MICA antibodies on kidney graft survival. PATIENTS AND METHODS    A random blood sample was collected from 457 kidney recipients during a regular outpatient visit. Patients who were less than 6 months after transplantation were excluded. Evaluation of anti‑HLA (classes I and II) and anti-MICA antibodies was performed with the use of Luminex assays. An outpatient registry was used to monitor kidney function during a 7‑year follow‑up. RESULTS    A total of 147 patients (32%) had anti‑HLA and 88 patients (19%) had anti‑MICA antibodies. Graft failure occurred in 67 anti‑HLA‑positive individuals (46%) as compared to 81 anti‑HLA‑negative ones (26%) (P <0.05), and in 30 anti‑MICA‑positive individuals (34%) as compared to 118 anti‑MICA‑negative ones (32%) (P = 0.52). Anti‑HLA antibodies were associated with increased incidence of graft failure: it was reported in 200 patients with an estimated glomerular filtration rate of more than 30 ml/min/1.73 m2 body surface area more than 5 years after transplantation (P <0.005). CONCLUSIONS    Anti‑HLA, but not anti‑MICA, antibodies in randomly obtained blood samples were the significant predictor of late kidney graft failure and could be a low‑cost method enabling identification of patients requiring an individualized posttransplant approach. The results of our study provide an additional rationale for investigating immune biomarkers in certain diseases.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 059832180

Download citation: RISBibTeXText

PMID: 28220766


Related references

Predicting long-term graft survival in adult kidney transplant recipients. Saudi Journal of Kidney Diseases and Transplantation 23(4): 693-700, 2012

Hypertension and decreased graft survival in long term kidney transplant recipients. Kidney International 27(1): 188, 1985

Influence of HBV and HCV infections on the survival of long-term follow-up of kidney graft recipients. Hepatology 18(4 Part 2): 328A, 1993

Effect of Prediabetes on Allograft Survival and Evolution of New-Onset Diabetes After Transplant in Deceased-Donor Kidney Transplant Recipients During Long-Term Follow-Up. Experimental and Clinical Transplantation 15(6): 620-626, 2017

Paradoxical behavior of long-term graft survival in highly sensitized kidney transplant recipients. Journal of Urology 163(4 Suppl ): 331, 2000

Graft failure due to noncompliance among 628 kidney transplant recipients with long-term follow-up: a single-center observational study. Transplantation 97(9): 925-933, 2014

Improved long term graft survival in pediatric donor kidney transplant recipients using quadruple immunosuppression. Journal of Urology 149(4 Suppl. ): 390A, 1993

Long-term Patient and Graft Survival of Kidney Transplant Recipients With Hepatitis C Virus Infection in the United States. Transplantation 102(3): 454-460, 2018

High regulatory T-cell levels at 1 year posttransplantation predict long-term graft survival among kidney transplant recipients. Transplantation Proceedings 44(9): 2538-2541, 2012

The impact of CMV prevention on long-term recipient and graft survival in heart transplant recipients: analysis of the Scientific Registry of Transplant Recipients (SRTR) database. Clinical Transplantation 25(4): E455-E462, 2012

Presence of vesicoureteral reflux in the graft kidney does not adversely affect long-term graft outcome in kidney transplant recipients. Transplantation Proceedings 45(8): 2984-2987, 2013

Immune regulation and graft survival in kidney transplant recipients are both enhanced by HLA-DR sharing. Human Immunology 64(Suppl. 1): S19, 2003

Long-term follow-up of pediatric transplant recipients: mycophenolic acid trough levels are not a good indicator for long-term graft function. Clinical Transplantation 18(5): 576-579, 2004

Clinical and pathological studies of cyclosporin-treated kidney transplant recipients. First report: Study of recipients with long-term graft function. Nihon Jinzo Gakkai Shi 30(7): 865-873, 1988

A personalized follow-up of kidney transplant recipients using video conferencing based on a 1-year scoring system predictive of long term graft failure (TELEGRAFT study): protocol for a randomized controlled trial. Bmc Nephrology 16: 6, 2015